Enhanced hit-to-lead process using bioanalogous lead evolution and chemogenomics: application in designing selective matrix metalloprotease inhibitors

Papp Á., Szommer T., Barna L., Gyimesi G., Ferdinandy P., Spadoni C., Darvas F., Fujita T., Ürge L., Dormán G.

DOI

10.1517/17460441.2.5.707

Type

Journal article

Journal

Expert Opinion on Drug Discovery

Publisher

Informa Healthcare

Publication Date

05/2007

Volume

2

Pages

707 - 723

Permalink Original publication